metformin has been researched along with Hepatitis B Virus Infection in 4 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The main risk factors for developing HCC are well known and include hepatitis B and C virus infection, alcohol intake and ingestion of the fungal metabolite aflatoxin B1." | 4.93 | Hepatocellular carcinoma. ( Gores, G; Llovet, JM; Pikarsky, E; Sangro, B; Schwartz, M; Sherman, M; Zucman-Rossi, J, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z | 1 |
| Liu, H | 1 |
| Li, X | 1 |
| Jiao, Y | 1 |
| Xing, Y | 1 |
| Gao, P | 1 |
| Llovet, JM | 1 |
| Zucman-Rossi, J | 1 |
| Pikarsky, E | 1 |
| Sangro, B | 1 |
| Schwartz, M | 1 |
| Sherman, M | 1 |
| Gores, G | 1 |
| Shen, C | 1 |
| Peng, C | 1 |
| Shen, B | 1 |
| Zhu, Z | 1 |
| Xu, N | 1 |
| Li, T | 1 |
| Xie, J | 1 |
2 reviews available for metformin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis.
Topics: Alcoholism; Diabetes Complications; Diabetes Mellitus; Glucose; Hepacivirus; Hepatitis B; Hepatitis | 2019 |
Hepatocellular carcinoma.
Topics: Aflatoxin B1; Alcohol Drinking; Carcinoma, Hepatocellular; Fibrosis; Hepatitis B; Hepatitis B Vaccin | 2016 |
2 other studies available for metformin and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
Topics: Carcinoma, Hepatocellular; Cell Transformation, Viral; Female; Hep G2 Cells; Hepatitis B; Hepatitis | 2018 |
Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Line | 2016 |